Skip to main content

Table 1 Baseline characteristics of the patients in the genomics study and IHC validation group

From: Gene expression profiling reveals activation of the FA/BRCA pathway in advanced squamous cervical cancer with intrinsic resistance and therapy failure

Characteristics

Genomics study group (n = 21)

IHC validation group (n = 24)

Median age (range), years

46 (27–73)

52 (28–62)

Median tumor size (range), cm

5 (2–8)

4 (2–7)

Median hemoglobin (range), g/dl

12.7 (7.9–14.4)

13.3 (10.2–14.9)

FIGO stage

II B

10

8

III A

5

11

III B

6

5

HPV subtype

HPV 16

16

19

Other high-risk*

3

3

Negative

2

2

Treatment response

CR

12

15

NCR

9

9

  1. *other high-risk in study group: 33,58,73.
  2. other high-risk in validation group: 31,45,58.
Back to article page

BMC Cancer

ISSN: 1471-2407

Contact us